Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

Britain will study whether the use of Eli Lilly’s weight loss drug can get people back into work and help tackle the high ...

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...

Eli Lilly (LLY) has partnered with the government of the United Kingdom to see if its blockbuster weight loss drug could help ...

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment ...

按照协议，礼来公司将启动一项“真实世界”研究，旨在了解替西帕肽（tirzepatide，其Zepbound和Mounjaro药物背后的GLP-1受体激动剂药物）如何影响减肥、糖尿病预防和肥胖相关并发症的预防，以更好地为英国国家卫生服务局（NHS）应对 ...

The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

Eli Lilly and Co. (LLY) is planning to invest $364 million or 279 million pounds in the biotechnology segment in the U.K., to ...

Britain is studying the use of Eli Lilly's weight loss drug, Tirzepatide, to address long-term sickness impacting its economy ...